{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:21:17Z","timestamp":1792135277778,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.ygyno.2005.12.045","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T05:51:57Z","timestamp":1146808317000},"page":"151-159","source":"Crossref","is-referenced-by-count":79,"title":["Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia"],"prefix":"10.1016","volume":"102","author":[{"given":"Laurence A.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Khanlian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almareena","family":"Giddings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn Y.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Seckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest I.","family":"Kohorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2005.12.045_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02778058","article-title":"Carbohydrate and peptide structure of the \u03b1- and \u03b2-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma","volume":"7","author":"Elliott","year":"1997","journal-title":"Endocrine"},{"key":"10.1016\/j.ygyno.2005.12.045_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinchem\/47.2.308","article-title":"Utility of commonly used commercial hCG immunoassays in the diagnosis and management of trophoblastic diseases","volume":"47","author":"Cole","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2005.12.045_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mob.2003.271","article-title":"Persistent low levels of hCG: a pre-malignant gestational trophoblastic disease","volume":"188","author":"Khanlian","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.12.045_bib4","first-page":"423","article-title":"Inappropriate management of women with persistent low hCG results","volume":"49","author":"Cole","year":"2004","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2005.12.045_bib5","first-page":"5","article-title":"Clinical management of persistent low level hCG elevation","volume":"4","author":"Hancock","year":"2003","journal-title":"Trophobl. Dis. Update"},{"key":"10.1016\/j.ygyno.2005.12.045_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/gyno.2002.6622","article-title":"Persistent low-level \u201creal\u201d human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma","volume":"85","author":"Kohorn","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.045_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00003081-200309000-00005","article-title":"hCG Tests in the management of gestational trophoblastic diseases","volume":"46","author":"Cole","year":"2003","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2005.12.045_bib8","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/clinchem\/45.12.2109","article-title":"Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening","volume":"45","author":"Cole","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2005.12.045_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0303-7207(02)00135-1","article-title":"Trophoblast origin of hCG isoforms: cytotrophoblasts are the primary source or choriocarcinoma-like hCG","volume":"194","author":"Kovaleskaya","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ygyno.2005.12.045_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ygyno.2005.12.047","article-title":"Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.045_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0009-9120(03)00108-5","article-title":"Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection","volume":"36","author":"Cole","year":"2003","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ygyno.2005.12.045_bib12","first-page":"139","article-title":"O-Glycosylation of proteins in the normal and neoplastic trophoblast","volume":"2","author":"Cole","year":"1987","journal-title":"Trophobl. Res."},{"key":"10.1016\/j.ygyno.2005.12.045_bib13","first-page":"147","article-title":"Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAR cells","volume":"13","author":"Lei","year":"1999","journal-title":"Trophobl. Res."},{"key":"10.1016\/j.ygyno.2005.12.045_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2005.12.046","article-title":"Gestational trophoblastic diseases: 3. Human chorionic gonadotropin free \u03b2-subunit, a reliable marker for placental site trophoblastic tumors","volume":"102","author":"Cole","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2005.12.045_bib15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2003.026989","article-title":"Between-method variation in hCG test results","volume":"50","author":"Cole","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ygyno.2005.12.045_bib16","first-page":"545","article-title":"Selecting an appropriate hCG test for management of gestational trophoblastic diseases and cancer cases","volume":"49","author":"Cole","year":"2004","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.ygyno.2005.12.045_bib17","series-title":"Gestational trophoblastic disease","first-page":"77","author":"Paradinas","year":"2003"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580600223X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580600223X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T12:54:45Z","timestamp":1586868885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082580600223X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S009082580600223X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2005.12.045","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}